| Deborah S Kelly, MD | |
|
51 N 39th St, Scheie Eye Institute, Philadelphia, PA 19104-2640 | |
| (215) 662-8113 | |
| (215) 243-4695 |
| Full Name | Deborah S Kelly |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 51 N 39th St, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073507703 | NPI | - | NPPES |
| 1239987 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD068639L (Pennsylvania) | Primary |
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
The Gray Board of Arbitration awarded OPSEU 2.5% wage increases in 2009 and 2010, as well as certain enhancements to benefits. The wage increases awarded are significantly higher than recent settlements in the public sector, including the Ontario Public Service Settlement with OPSEU, the City of Toronto settlement with the Canadian Union of Public Employees (CUPE), and hospital settlements with CUPE and the Canadian Auto Workers (CAW).
NovoCure, Ltd., a privately held medical device company focused on developing the Novo-TTF device, a non-invasive portable medical device for the treatment of cancer, announced the completion of a new funding round today. Key investors in this round included Pfizer Inc, Johnson & Johnson Development Corporation and Index Ventures.
StemCells, Inc. today announced the publication of preclinical data demonstrating for the first time that transplantation of its proprietary, purified human neural stem cells delays the loss of motor function in a mouse model of infantile neuronal ceroid lipofuscinosis (NCL).
If a tomato is bright red, round and reasonably large, it should be a tasty tomato, right? Wrong!
New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah S Kelly, MD 51 N 39th St, Scheie Eye Institute, Philadelphia, PA 19104-2640 Ph: (215) 662-8113 | Deborah S Kelly, MD 51 N 39th St, Scheie Eye Institute, Philadelphia, PA 19104-2640 Ph: (215) 662-8113 |
News Archive
The Gray Board of Arbitration awarded OPSEU 2.5% wage increases in 2009 and 2010, as well as certain enhancements to benefits. The wage increases awarded are significantly higher than recent settlements in the public sector, including the Ontario Public Service Settlement with OPSEU, the City of Toronto settlement with the Canadian Union of Public Employees (CUPE), and hospital settlements with CUPE and the Canadian Auto Workers (CAW).
NovoCure, Ltd., a privately held medical device company focused on developing the Novo-TTF device, a non-invasive portable medical device for the treatment of cancer, announced the completion of a new funding round today. Key investors in this round included Pfizer Inc, Johnson & Johnson Development Corporation and Index Ventures.
StemCells, Inc. today announced the publication of preclinical data demonstrating for the first time that transplantation of its proprietary, purified human neural stem cells delays the loss of motor function in a mouse model of infantile neuronal ceroid lipofuscinosis (NCL).
If a tomato is bright red, round and reasonably large, it should be a tasty tomato, right? Wrong!
New data from a study of patients with treatment-resistant depression who underwent deep brain stimulation (DBS) in the subcallosal cingulate region (SCG or Cg25) of the brain shows that this intervention is generally safe and provides significant improvement in patients as early as one month after treatment. The patients also experienced continued and sustained improvement over time.
› Verified 9 days ago
Jonathan Tsui, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 51 N. 39th Street, Philadelphia, PA 19104 Phone: 215-662-8100 Fax: 215-662-1721 | |
Dr. Hugo Manuel Linares, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2701 Holme Ave Ste 303, Philadelphia, PA 19152 Phone: 215-335-3088 Fax: 215-335-0315 | |
Dr. Qi N Cui, M.D., PH.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3801 Filbert St, Philadelphia, PA 19104 Phone: 215-662-8100 | |
Dr. Christopher William Ahmed, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3509 N Broad St, Philadelphia, PA 19140 Phone: 800-836-7536 | |
Dr. Jonathan S Myers, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 840 Walnut St Ste 1110, Philadelphia, PA 19107 Phone: 215-928-3197 Fax: 215-928-0166 | |
Dilru Cheryl Amarasekera, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 840 Walnut St Ste 1110, Philadelphia, PA 19107 Phone: 215-928-3197 | |
Tomas Enrique Meijome, MD, MS Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 51 N 39th St, Philadelphia, PA 19104 Phone: 215-316-5151 |